ENAGenomicsAssay Development Group, Drug Discovery, Experimental Therapeutics Centrehttps://www.ebi.ac.uk/ena/browser/view/PRJNA118715Homo sapiensHCT116 wild type cells express p53. The isogenic HCT116 p53KO cells have the p53 gene knocked out. Cells were treated for 16 hours. Dosages for leptomycin B treatment was 2 nM and 20 nM. Overall design: Measuring the gene expression profile of the isogenic cell lines when the cells were treated with leptomycin B at different concentrationsENAbeta[[3]]-Tub, DmelCG17117, dp53, HCT116, p50, p53, 143391_i_at, beta3 TU, LFS1, betaTub3, Tp53, 19-(3, l(3)05745, 10, 11, 12, 16, DMP53, bbl, 2, Dmp53, 5, anon-EST:Liang-2.13, 7, 9, 1323/07, 6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-17-ethyl-6-hydroxy-3, clone 2.13, BCC7, D.m.BETA-60D, beta-Tub6D, dmp53, T, 18-nonadecapentaenoic acid, DmP53, 1422/04, 15-hexamethyl-8-oxo-, B3t, DmelCG3401, Trp53, Dp53, betaTub60C, beta3-tubulin, beta[[3]]-tubulin, TRP53, CG17117, p50/tubulin, beta-Tub60D, CG10873, Dmbeta3, Dm-HTH, BETA 60D, prac, beta3t, beta3-Tub, Cell, Xp53, 3t, HCT116 cell, p53/tubulin, bfy, 720, beta[[3]] tubulin, Tub60D, HTH, Hth, CG33336, beta-tub, elactocin, HCT-116, DmelCG33336, D-p53, beta60C, CG3401, CI 940, beta3Tub, beta3TUB, Dm-P53, l(3)86Ca, beta3, dtl, Tub, CI-940, DTB3, Meis1, hth1, hth2, PD 114720., HCT 116, betatub60D, PD-114, P53, p44, bhy, HCT-116 cell, CG31325, betaTubHuman, Modern., human being, Man (Taxonomy), Homo sapiens, man, Man, human, Modern ManfalseHomo sapiensExpression profile of HCT116 p53+/+ and P53-/- cells treated with Leptomycin B2025-09-242014-02-11PRJNA118715GSE174729606